Guardant Health, Inc. ($GH)
Filing Information
| Accession Number | 0001702824-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 17, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
37,993
Total Value
$894,848.37
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Mar 15, 2026 | Exercise/Conversion | 1,233 | $0.00 | $0.00 | 41,457 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 15, 2026 | Exercise/Conversion | 10,518 | $0.00 | $0.00 | 51,975 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 15, 2026 | Exercise/Conversion | 2,039 | $0.00 | $0.00 | 54,014 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 15, 2026 | Tax Withholding | 7,413 | $85.49 | $633,737.37 | 46,601 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 16, 2026 | Sale | 3,000 | $87.04 | $261,111.00 | 43,601 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Mar 15, 2026 | Exercise/Conversion | 1,233 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Financial Officer | Performance-Based Restricted Stock Units | Derivative | Mar 15, 2026 | Exercise/Conversion | 10,518 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Mar 15, 2026 | Exercise/Conversion | 2,039 | $0.00 | $0.00 | 2,039 | Direct | โ | View Details |